Sign in or create an account to add this stock to your watchlist.
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage; and run-off settlement annuity contracts. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Industry, Sector and Symbol
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorFinance
SymbolNYSE:CI
CUSIP12550910
Phone860-226-6000
Debt
Debt-to-Equity Ratio0.37
Current Ratio0.35
Quick Ratio0.35
Price-To-Earnings
Trailing P/E Ratio16.81
Forward P/E Ratio13.29
P/E Growth1.09
Sales & Book Value
Annual Sales$41.62 billion
Price / Sales1.03
Cash Flow$13.0163 per share
Price / Cash13.51
Book Value$58.35 per share
Price / Book3.01
Profitability
EPS (Most Recent Fiscal Year)$10.46
Net Income$2.24 billion
Net Margins5.99%
Return on Equity20.90%
Return on Assets4.76%
Miscellaneous
Employees46,000
Outstanding Shares243,270,000
Cigna (NYSE:CI) Frequently Asked Questions
What is Cigna's stock symbol?
Cigna trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."
How often does Cigna pay dividends? What is the dividend yield for Cigna?
Cigna declared a quarterly dividend on Wednesday, February 28th. Investors of record on Monday, March 12th will be paid a dividend of $0.04 per share on Tuesday, April 10th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.09%. The ex-dividend date of this dividend is Friday, March 9th. View Cigna's Dividend History.
How will Cigna's stock buyback program work?
Cigna announced that its board has approved a stock buyback program on Sunday, June 4th 2017, which authorizes the company to repurchase $3,700,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase up to 9.8% of its shares through open market purchases. Shares repurchase programs are generally an indication that the company's management believes its shares are undervalued.
How were Cigna's earnings last quarter?
Cigna (NYSE:CI) announced its quarterly earnings results on Thursday, May, 3rd. The health services provider reported $4.11 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $3.39 by $0.72. The health services provider had revenue of $11.38 billion for the quarter, compared to the consensus estimate of $10.97 billion. Cigna had a return on equity of 20.90% and a net margin of 5.99%. The firm's quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the firm posted $2.77 earnings per share. View Cigna's Earnings History.
When is Cigna's next earnings date?
What guidance has Cigna issued on next quarter's earnings?
Cigna issued an update on its FY18 earnings guidance on Thursday, May, 3rd. The company provided earnings per share (EPS) guidance of $12.85-13.25 for the period, compared to the Thomson Reuters consensus EPS estimate of $12.78. The company issued revenue guidance of +7-8% to ~$44.53-44.95 billion, compared to the consensus revenue estimate of $44.08 billion.
What price target have analysts set for CI?
17 analysts have issued 12-month price targets for Cigna's stock. Their predictions range from $174.00 to $255.00. On average, they anticipate Cigna's share price to reach $211.4118 in the next year. View Analyst Ratings for Cigna.
What are Wall Street analysts saying about Cigna stock?
Here are some recent quotes from research analysts about Cigna stock:
- 1. According to Zacks Investment Research, "Cigna’s shares have underperformed the industry in a year. The company has been witnessing increase in leverage. Suspension of share buyback and huge execution risk related to the recent deal are some of the major concerns. Its Medicare business is also expected to remain under pressure. The company has also received negative rating action from the rating agencies. However, the company is on track to buy Express Scripts, which should raise its rank in the health insurance industry and equip it better to face stiff competition. Synergies from the acquisition should buoy the company's long-term growth potential. Its robust Global Supplemental business, growing Government business and increasing membership, and strong capital position are the other positives. A strong outlook for 2018 reflects its business strength. Moreover, it has seen the Zacks Consensus Estimate for 2018 earnings being revised upward in the last 30 days." (4/16/2018)
- 2. Jefferies Group LLC analysts commented, "CI reported Q2:17 adjusted EPS of $2.91 (GAAP $3.15), compared to OPCO’s estimate of $2.46 and Street consensus of $2.45. Adjusted results exclude $0.13 of realized investment gains and $0.18 from merger-related tax benefits, offset by $0.07 of amortization expense. The beat was driven by the Healthcare segment, with the Commercial MCR of 78.7% outperforming OPCO/Street estimates by 200/160 bps. Due to the beat, the company raised FY2017 EPS guidance to $9.75-$10.05 vs. $9.35-$9.85, with all three segment outlooks growing by $15-$40M." (8/4/2017)
Who are some of Cigna's key competitors?
Who are Cigna's key executives?
Cigna's management team includes the folowing people:
- Mr. David Michael Cordani, Pres, CEO & Director (Age 53)
- Ms. Nicole Susan Jones, Exec. VP & Gen. Counsel (Age 47)
- Mr. Jason D. Sadler, Pres of International Markets (Age 49)
- Mr. Eric Paul Palmer, Exec. VP & CFO (Age 41)
- Ms. Mary Terese Agoglia Hoeltzel CPA, VP & Chief Accounting Officer
Has Cigna been receiving favorable news coverage?
Headlines about CI stock have been trending positive on Thursday, according to Accern Sentiment. The research firm identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cigna earned a news impact score of 0.26 on Accern's scale. They also assigned news articles about the health services provider an impact score of 46.96 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.
Who are Cigna's major shareholders?
Cigna's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.13%), Massachusetts Financial Services Co. MA (2.24%), Northern Trust Corp (1.24%), Boston Partners (1.19%), Veritas Asset Management LLP (1.01%) and Swedbank (0.90%). Company insiders that own Cigna stock include Alan Muney, Christopher J Hocevar, David Cordani, Donna F Zarcone, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Institutional Ownership Trends for Cigna.
Which institutional investors are selling Cigna stock?
CI stock was sold by a variety of institutional investors in the last quarter, including Artisan Partners Limited Partnership, LSV Asset Management, Winslow Capital Management LLC, Pzena Investment Management LLC, Westwood Holdings Group Inc., Thrivent Financial for Lutherans, American Century Companies Inc. and Element Capital Management LLC. Company insiders that have sold Cigna company stock in the last year include Alan Muney, Christopher J Hocevar, David Cordani, Donna F Zarcone, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones and William D Zollars. View Insider Buying and Selling for Cigna.
Which institutional investors are buying Cigna stock?
CI stock was purchased by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, Massachusetts Financial Services Co. MA, Old Mutual Global Investors UK Ltd., Levin Capital Strategies L.P., Natixis, MUFG Securities EMEA plc, Swedbank and Wedge Capital Management L L P NC. View Insider Buying and Selling for Cigna.
How do I buy shares of Cigna?
Shares of CI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cigna's stock price today?
One share of CI stock can currently be purchased for approximately $175.85.
How big of a company is Cigna?
Cigna has a market capitalization of $43.12 billion and generates $41.62 billion in revenue each year. The health services provider earns $2.24 billion in net income (profit) each year or $10.46 on an earnings per share basis. Cigna employs 46,000 workers across the globe.
How can I contact Cigna?
Cigna's mailing address is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The health services provider can be reached via phone at 860-226-6000 or via email at [email protected]
MarketBeat Community Rating for Cigna (CI)
MarketBeat's community ratings are surveys of what our community members think about Cigna and other stocks. Vote "Outperform" if you believe CI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CI will underperform the S&P 500 over the long term. You may vote once every thirty days.
Cigna (NYSE:CI) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
17 Wall Street analysts have issued ratings and price targets for Cigna in the last 12 months. Their average twelve-month price target is $211.4118, suggesting that the stock has a possible upside of 20.22%. The high price target for CI is $255.00 and the low price target for CI is $174.00. There are currently 4 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Buy | Buy | Buy | Buy |
| Consensus Rating Score: | 2.76 | 2.78 | 2.81 | 2.87 |
| Ratings Breakdown: | 0 Sell Rating(s)
4 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
3 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) | 0 Sell Rating(s)
2 Hold Rating(s)
13 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $211.4118 | $209.2222 | $208.8125 | $200.6667 |
| Price Target Upside: | 20.22% upside | 25.05% upside | 0.66% upside | 0.61% downside |
Cigna (NYSE:CI) Consensus Price Target History
Cigna (NYSE:CI) Analyst Ratings History
Show:
(Data available from 5/24/2016 forward)
Cigna (NYSE:CI) Dividend Information
Cigna pays an annual dividend of $0.04 per share, with a dividend yield of 0.02%. CI's most recent quarterly dividend payment was Tuesday, April 10. Cigna pays out 0.38% of its earnings out as a dividend.
| Most Recent Dividend: | 4/10/2018 |
| Annual Dividend: | $0.04 |
| Dividend Yield: | 0.02% |
| Dividend Growth: | 0.00% (3 Year Average) |
| Payout Ratio(s): | 0.38% (Trailing 12 Months of Earnings)
0.30% (Based on This Year's Estimates)
0.27% (Based on Next Year's Estimates)
0.31% (Based on Cash Flow)
|
Cigna (NYSE:CI) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 2/28/2018 | quarterly | $0.04 | 0.1% | 3/9/2018 | 3/12/2018 | 4/10/2018 |
| 2/22/2017 | quarterly | $0.04 | 0.03% | 3/8/2017 | 3/10/2017 | 4/10/2017 |
| 2/25/2016 | annual | $0.04 | 0.03% | 3/9/2016 | 3/11/2016 | 4/11/2016 |
| 2/26/2015 | annual | $0.04 | 0.03% | 3/10/2015 | 3/12/2015 | 4/10/2015 |
| 2/26/2014 | quarterly | $0.04 | 0.05% | 3/10/2014 | 3/12/2014 | 4/9/2014 |
| 3/1/2013 | annual | $0.04 | 0.07% | 3/8/2013 | 3/12/2013 | 4/10/2013 |
| 2/28/2013 | quarterly | $0.04 | | | 3/12/2013 | 4/10/2013 |
(Data available from 1/1/2013 forward)
Cigna (NYSE CI) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.10%
Institutional Ownership Percentage: 87.75%
Cigna (NYSE CI) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 3/5/2018 | Christopher J Hocevar | Insider | Sell | 2,759 | $191.84 | $529,286.56 | 12,784 |  |
| 3/5/2018 | David Cordani | CEO | Sell | 36,769 | $191.68 | $7,047,881.92 | 372,076 | |
| 3/5/2018 | Nicole S Jones | EVP | Sell | 5,856 | $190.68 | $1,116,622.08 | 36,658 | |
| 1/18/2018 | John M Murabito | EVP | Sell | 6,099 | $220.10 | $1,342,389.90 | 68,026 | |
| 1/16/2018 | Donna F. Zarcone | Director | Sell | 5,971 | $215.43 | $1,286,332.53 | | |
| 1/12/2018 | Jane E. Md Henney | Director | Sell | 400 | $212.96 | $85,184.00 | | |
| 1/10/2018 | John M Murabito | EVP | Sell | 28,037 | $205.68 | $5,766,650.16 | 60,290 | |
| 1/10/2018 | William D Zollars | Director | Sell | 212 | $205.68 | $43,604.16 | 13,500 | |
| 12/11/2017 | Isaiah Harris, Jr. | Chairman | Sell | 212 | $209.35 | $44,382.20 | | |
| 11/27/2017 | Alan Muney | EVP | Sell | 15,345 | $200.80 | $3,081,276.00 | 28,457 | |
| 11/27/2017 | Christopher J Hocevar | Insider | Sell | 8,387 | $200.32 | $1,680,083.84 | 12,363 | |
| 11/13/2017 | Michael W Triplett | Insider | Sell | 10,417 | $197.77 | $2,060,170.09 | 32,347 | |
| 11/9/2017 | Mary T Hoeltzel | CAO | Sell | 575 | $197.03 | $113,292.25 | 2,499 | |
| 9/13/2017 | William D. Zollars | Director | Sell | 1,232 | $187.23 | $230,667.36 | | |
| 9/12/2017 | Isaiah Harris, Jr. | Chairman | Sell | 247 | $185.27 | $45,761.69 | | |
| 8/16/2017 | Lisa R Bacus | EVP | Sell | 2,236 | $179.95 | $402,368.20 | 18,501 | |
| 8/9/2017 | Mary T Hoeltzel | VP | Sell | 525 | $177.59 | $93,234.75 | 1,924 | |
| 8/8/2017 | Michael W Triplett | Insider | Sell | 3,700 | $174.96 | $647,352.00 | 21,060 | |
| 8/7/2017 | Jason D Sadler | Insider | Sell | 37,756 | $176.16 | $6,651,096.96 | 47,844 | |
| 7/24/2017 | Jane E. Md Henney | Director | Sell | 600 | $174.14 | $104,484.00 | | |
| 7/21/2017 | Matthew G Manders | Insider | Sell | 24,357 | $175.01 | $4,262,718.57 | 46,256 | |
| 6/19/2017 | David Cordani | CEO | Sell | 153,168 | $170.20 | $26,069,193.60 | 421,162 | |
| 6/14/2017 | Michael W Triplett | Insider | Sell | 1,439 | $166.89 | $240,154.71 | 26,199 | |
| 6/6/2017 | Mary T Hoeltzel | VP | Sell | 500 | $166.70 | $83,350.00 | 2,449 | |
| 6/5/2017 | Jason D Sadler | Insider | Sell | 1,727 | $164.59 | $284,246.93 | 34,504 | |
| 6/2/2017 | Matthew G Manders | Insider | Sell | 6,000 | $165.00 | $990,000.00 | 33,799 | |
| 5/24/2017 | Lisa R Bacus | EVP | Sell | 11,455 | $161.57 | $1,850,784.35 | 24,753 | |
| 5/17/2017 | Nicole S Jones | EVP | Sell | 20,312 | $160.04 | $3,250,732.48 | 44,737 | |
| 4/24/2017 | Jane E. Md Henney | Director | Sell | 600 | $156.92 | $94,152.00 | | |
| 4/10/2017 | Jason D Sadler | Insider | Sell | 4,213 | $152.01 | $640,418.13 | 36,231 | |
| 2/27/2017 | David Cordani | CEO | Sell | 43,637 | $147.78 | $6,448,675.86 | 306,194 | |
| 2/27/2017 | Matthew G Manders | Insider | Sell | 8,309 | $146.54 | $1,217,600.86 | 39,799 | |
| 2/27/2017 | Thomas A Mccarthy | CFO | Sell | 4,464 | $146.54 | $654,154.56 | 80,531 | |
| 12/20/2016 | Jason D Sadler | Insider | Sell | 2,000 | $138.10 | $276,200.00 | 32,019 | |
| 11/7/2016 | John M Murabito | EVP | Sell | 58,822 | $125.09 | $7,358,043.98 | 115,109 | |
| 10/31/2016 | Jason D Sadler | Insider | Sell | 4,000 | $121.80 | $487,200.00 | 34,019 | |
| 8/17/2016 | Mary T Hoeltzel | VP | Sell | 500 | $132.28 | $66,140.00 | 4,017 | |
| 12/8/2015 | Isaiah Harris Jr | Chairman | Sell | 333 | $137.00 | $45,621.00 | 13,500 | |
| 11/16/2015 | Herbert A. Fritch | insider | Sell | 40,157 | $133.18 | $5,348,109.26 | 274,545 | |
| 10/15/2015 | Herbert A. Fritch | insider | Sell | 39,202 | $136.66 | $5,357,345.32 | 279,313 | |
| 9/15/2015 | Herbert A. Fritch | insider | Sell | 39,174 | $139.66 | $5,471,040.84 | 283,125 | |
| 8/17/2015 | Herbert A Fritch | Insider | Sell | 38,489 | $144.36 | $5,556,272.04 | | |
| 7/15/2015 | Herbert A Fritch | Insider | Sell | 37,918 | $155.96 | $5,913,691.28 | | |
| 6/15/2015 | Herbert A Fritch | Insider | Sell | 38,045 | $145.15 | $5,522,231.75 | | |
| 6/8/2015 | Isaiah Harris Jr | Chairman | Sell | 319 | $139.48 | $44,494.12 | | |
| 4/15/2015 | Herbert A Fritch | Insider | Sell | 38,080 | $132.99 | $5,064,259.20 | | |
| 3/16/2015 | Herbert A Fritch | Insider | Sell | 38,377 | $124.40 | $4,774,098.80 | | |
| 3/9/2015 | Isaiah Harris Jr | Chairman | Sell | 369 | $120.64 | $44,516.16 | | |
| 3/2/2015 | Nicole S Jones | EVP | Sell | 8,659 | $121.88 | $1,055,358.92 | | |
| 2/10/2015 | Mary T Hoeltzel | CAO | Sell | 6,805 | $113.29 | $770,938.45 | | |
| 1/15/2015 | Herbert A Fritch | Insider | Sell | 35,864 | $107.04 | $3,838,882.56 | | |
| 12/15/2014 | Herbert A Fritch | Insider | Sell | 35,929 | $101.67 | $3,652,901.43 | | |
| 12/8/2014 | Isaiah Harris Jr | Chairman | Sell | 437 | $104.60 | $45,710.20 | | |
| 12/1/2014 | John M Murabito | EVP | Sell | 12,000 | $102.76 | $1,233,120.00 | | |
| 9/10/2014 | Jane E Md Henney | Director | Sell | 475 | $95.98 | $45,590.50 | | |
| 8/18/2014 | Jason D Sadler | Insider | Sell | 11,000 | $93.02 | $1,023,220.00 | | |
| 8/1/2014 | Isaiah Harris Jr | Chairman | Sell | 1,066 | $90.22 | $96,174.52 | | |
| 6/13/2014 | Thomas A Mccarthy | CFO | Sell | 7,206 | $90.26 | $650,413.56 | | |
| 6/12/2014 | Nicole S Jones | EVP | Sell | 1,882 | $91.02 | $171,299.64 | | |
| 6/11/2014 | John M Murabito | EVP | Sell | 17,519 | $91.25 | $1,598,608.75 | | |
| 6/10/2014 | David Cordani | CEO | Sell | 133,523 | $89.73 | $11,981,018.79 | | |
| 6/2/2014 | David D Guilmette | Insider | Sell | 6,591 | $90.19 | $594,442.29 | | |
| 5/13/2014 | Jason Sadler | Insider | Sell | 6,145 | $88.50 | $543,832.50 | 20,879 | |
| 5/12/2014 | Matthew Manders | Insider | Sell | 9,905 | $87.79 | $869,559.95 | 51,736 | |
| 5/8/2014 | Jason Sadler | Insider | Sell | 7,810 | $85.59 | $668,457.90 | 27,024 | |
| 5/7/2014 | Mary Hoeltzel | CAO | Sell | 3,000 | $85.00 | $255,000.00 | 1,691 | |
| 3/14/2014 | John Murabito | EVP | Sell | 29,843 | $76.70 | $2,288,958.10 | 101,810 | |
| 3/14/2014 | Mary Hoeltzel | CAO | Sell | 5,333 | $77.72 | $414,480.76 | 1,691 | |
| 9/12/2013 | Nicole Jones | EVP | Sell | 1,530 | $82.35 | $125,995.50 | 5,337 | |
| 9/6/2013 | John M Murabito | EVP | Sell | 24,333 | $81.07 | $1,972,676.31 | | |
| 8/16/2013 | Jason Sadler | Insider | Sell | 13,261 | $77.81 | $1,031,838.41 | 22,189 | |
| 8/14/2013 | Mary Hoeltzel | CAO | Sell | 8,664 | $78.26 | $678,044.64 | 1,979 | |
| 8/7/2013 | John Murabito | EVP | Sell | 78,589 | $77.89 | $6,121,297.21 | 143,546 | |
| 6/13/2013 | David Cordani | CEO | Sell | 58,705 | $68.63 | $4,028,924.15 | | |
| 6/12/2013 | Matthew G Manders | Insider | Sell | 36,868 | $68.75 | $2,534,675.00 | | |
| 6/12/2013 | Nicole S Jones | EVP | Sell | 15,306 | $70.08 | $1,072,644.48 | | |
| 6/5/2013 | Isaiah Harris Jr | Chairman | Sell | 5,312 | $67.40 | $358,028.80 | | |
| 3/11/2013 | Mary T Hoeltzel | CAO | Sell | 5,712 | $60.50 | $345,576.00 | | |
| 3/6/2013 | Eric C Wiseman | Director | Buy | 4,200 | $59.30 | $249,060.00 | | |
(Data available from 1/1/2013 forward)
Cigna (NYSE CI) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Cigna (CI) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 24 at 1:47 PM |
 | Cigna Corporation Announces Appearance at the Goldman Sachs 39
www.businesswire.com - May 23 at 9:00 AM |
 | Cigna Corporation Announces Appearance at the Goldman Sachs 39th Annual Global Healthcare Conference
finance.yahoo.com - May 23 at 9:00 AM |
| Priority Health announces new agreement with Cigna Payer Solutions
www.businesswire.com - May 22 at 9:08 AM |
| Zacks: Brokerages Expect Cigna (CI) Will Post Quarterly Sales of $11.15 Billion
www.americanbankingnews.com - May 17 at 2:52 AM |
| Cigna Furthers its Commitment to Help Curb the National Opioid Epidemic
finance.yahoo.com - May 16 at 9:57 AM |
| Zacks: Brokerages Expect Cigna (CI) Will Post Earnings of $3.56 Per Share
www.americanbankingnews.com - May 15 at 3:31 PM |
| U.S. to consider expanding Medicare drug price negotiation
finance.yahoo.com - May 14 at 4:36 PM |
 | Moneyism: 4 reasons Americans are lonely
www.marketwatch.com - May 12 at 11:21 AM |
 | Here's What Wall Street Says About Trump's Drug Pricing Plan
www.bloomberg.com - May 11 at 4:44 PM |
| Free Research Report as Anthem’s EPS Surged 34%
finance.yahoo.com - May 11 at 10:28 AM |
 | Even After Earnings Beat, Cigna Corporation Stock Still Looks Stuck
investorplace.com - May 11 at 4:42 AM |
| Cigna to Post Q1 2019 Earnings of $4.34 Per Share, Piper Jaffray Forecasts (CI)
www.americanbankingnews.com - May 10 at 8:52 AM |
| Cigna Named to Corporate Responsibility Magazine’s 100 Best Corporate Citizens List for Fourth Consecutive Year
finance.yahoo.com - May 9 at 4:34 PM |
| 8 Bold Thoughts on the Future of Healthcare
finance.yahoo.com - May 9 at 4:34 PM |
| Cigna to Post Q2 2018 Earnings of $3.50 Per Share, Piper Jaffray Forecasts (CI)
www.americanbankingnews.com - May 9 at 8:48 AM |
| Cigna Corporation Announces Appearance at the 2018 Bank of America Merrill Lynch Health Care Conference
www.businesswire.com - May 7 at 4:37 PM |
| FY2019 EPS Estimates for Cigna (CI) Lifted by Analyst
www.americanbankingnews.com - May 7 at 5:04 AM |
| Q3 2018 EPS Estimates for Cigna Decreased by Jefferies Group (CI)
www.americanbankingnews.com - May 7 at 3:23 AM |
| Research Analysts Offer Predictions for Cigna's Q2 2018 Earnings (CI)
www.americanbankingnews.com - May 7 at 2:32 AM |
| Insurers Post Obamacare Profits With Little Interest In Trump Plans
finance.yahoo.com - May 6 at 4:40 PM |
| Cigna beats earnings expectations, raises outlook
www.marketwatch.com - May 5 at 9:31 AM |
| Cigna (CI) PT Raised to $218.00
www.americanbankingnews.com - May 4 at 6:49 PM |
| Edited Transcript of CI earnings conference call or presentation 3-May-18 12:30pm GMT
finance.yahoo.com - May 4 at 9:17 AM |
| Cigna CEO: There's a lot of noise around regulatory concern of Express Scripts deal
finance.yahoo.com - May 3 at 4:31 PM |
| Cigna CEO Says Insurer Can Adapt to Drug-Price Shift After Deal
finance.yahoo.com - May 3 at 4:31 PM |
| Dow Rises Slightly but S&P 500 and Nasdaq Finish Lower After Volatile Session
finance.yahoo.com - May 3 at 4:31 PM |
| Cigna (CI) Posts Earnings Results
www.americanbankingnews.com - May 3 at 3:16 PM |
| Cigna (CI) Releases FY18 Earnings Guidance
www.americanbankingnews.com - May 3 at 10:58 AM |
| Cigna Reports Strong First Quarter 2018 Results, Raises Outlook
www.businesswire.com - May 3 at 9:16 AM |
 | Cigna Q1 revenues up 10%; non-GAAP EPS up 48%; updates guidance
seekingalpha.com - May 3 at 9:16 AM |
 | BRIEF-Cigna Reports Q1 EPS $3.72
www.reuters.com - May 3 at 9:16 AM |
| Gen Z is the loneliest generation, survey reveals, but working can help
finance.yahoo.com - May 2 at 4:34 PM |
| This is America’s loneliest generation
finance.yahoo.com - May 2 at 4:34 PM |
 | Why Earnings Season Could Be Great for Cigna (CI)
www.zacks.com - May 2 at 9:17 AM |
 | Young Americans are the loneliest, surprising study from Cigna shows
www.usatoday.com - May 1 at 9:19 AM |
 | Un nuevo estudio de Cigna revela que la soledad ha alcanzado niveles epidémicos en los Estados Unidos
www.prnewswire.com - May 1 at 6:08 AM |
| Cigna CEO: So Far So Good With Trump Administration on Express Scripts Deal
finance.yahoo.com - April 30 at 4:34 PM |
| Cigna CEO Is Still Bullish on Completing $52 Billion Express Scripts Deal
finance.yahoo.com - April 30 at 4:34 PM |
| Cigna (CI) Expected to Post Quarterly Sales of $11.03 Billion
www.americanbankingnews.com - April 30 at 7:08 AM |
| Cigna (CI) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - April 29 at 1:36 PM |
| Brokerages Anticipate Cigna (CI) Will Post Earnings of $3.37 Per Share
www.americanbankingnews.com - April 28 at 3:22 AM |
| Colorado hospitals, insurers offering pain alternatives to reduce opioid usage
finance.yahoo.com - April 26 at 9:20 AM |
| At $171.29, Is It Time To Buy Cigna Corporation (NYSE:CI)?
finance.yahoo.com - April 26 at 9:20 AM |
| Cigna (CI) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - April 26 at 1:04 AM |
| BRIEF-Cigna-On April 23, Co, Express Scripts Each Received Request For Additional Info, Documentary Material From ...
www.reuters.com - April 24 at 9:22 AM |
 | Department of Justice requests additional info on Cigna/Express Scripts deal
www.bizjournals.com - April 24 at 9:22 AM |
| Amazon’s Healthcare Venture: An Opportunity for Microsoft?
finance.yahoo.com - April 24 at 9:22 AM |
| Glenview's Larry Robbins is hot on health care stocks again
finance.yahoo.com - April 24 at 9:22 AM |
| UBS Reaffirms Buy Rating for Cigna (CI)
www.americanbankingnews.com - April 20 at 5:52 PM |
Cigna (NYSE:CI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Cigna (NYSE:CI) Income Statement, Balance Sheet and Cash Flow Statement
Cigna (NYSE CI) Stock Chart for Thursday, May, 24, 2018
Loading chart…
